BIIB091
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BIIB091, covering 2024-05-23 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS) [Phase 2]